Smart Health Wearables Landmark: UTime Subsidiary Secures 50,000-Unit Mega Order, Opening New Chapter for UTime’s Expansion into the North American Market

Rhea-AI Summary

UTime (Nasdaq: WTO) announced that its Hong Kong subsidiary signed a commercial sales agreement worth nearly $10 million with Denver-based Tumu Vertex LLC for an initial purchase order of 50,000 smart health devices.

The order is described as 25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring, with FOB Hong Kong delivery, phased payments, joint quality-control procedures, and first deliveries starting in Q1 2026. UTime highlights FDA-certified medical-grade monitoring integrated into everyday wearables and positions the deal as a strategic entry into the North American medical-grade wearable market.

Positive

• Signed nearly $10 million sales agreement for 50,000 devices
• Order split: 25,000 UT-168 watches and 25,000 UR08 rings
• First deliveries scheduled in Q1 2026
• Agreement uses FOB Hong Kong, phased payments, joint QC

Negative

• Customer concentration: single 50,000-unit initial order
• Revenue and shipment timing tied to phased payments and delivery

Key Figures

Order value nearly $10 million USD Smart health device procurement agreement with Tumu Vertex LLC

Total units ordered 50,000 units Initial purchase order under Sales Agreement

UT-168 BT Blood Pressure Watch 25,000 units Portion of 50,000-unit order

UR08 ECG Smart Ring 25,000 units Portion of 50,000-unit order

UT-368 4G Blood Pressure Watch 25,000 units Additional product line in order

UR01 Smart Ring 25,000 units Additional product line in order

First delivery timing Q1 2026 Initial batch of products to begin delivery

Market Reality Check

$0.8401 Last Close

Volume Volume 178,123 is at 0.85x the 20-day average of 208,486, not indicating heavy pre-news positioning. normal

Technical Shares at $0.6332 are trading well below the 200-day MA of $96.59, reflecting a heavily depressed longer-term trend into this announcement.

Peers on Argus 1 Up 1 Down

Peer moves are mixed: VUZI shows a price change of 8.91% today while KOSS and GPRO are negative and UEIC and AXIL are modestly positive. Momentum scanner data also shows UEIC up 11.91% and VUZI down 4.16% with no peer news, suggesting WTO’s news is company-specific rather than a sector-wide driver.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Nov 12	Reverse stock split	Negative	-5.3%	1-for-100 reverse split to support Nasdaq minimum bid compliance.
Nov 05	Market expansion	Positive	-0.2%	Plans to expand smart wearable distribution through global channels and partners.
Nov 03	AI R&D update	Positive	+14.5%	Research into AI models for health data and hypertension risk assessment.
Oct 30	Product launch	Positive	-10.7%	Launch of smart ring focused on sleep and continuous health monitoring.
Oct 28	Product launch	Positive	+2.4%	Launch of smartwatch with integrated blood pressure monitoring and NMPA registration.

Pattern Detected

Product and market-expansion news have often seen muted or negative immediate reactions, while AI/R&D updates and the reverse split aligned more clearly with subsequent price moves.

Recent Company History

Over the last few months, UTime has focused on health-oriented wearables and capital actions. On Oct 28, 2025, it launched a smartwatch with integrated blood pressure monitoring, followed by a smart ring on Oct 30, 2025. On Nov 3, 2025, it highlighted AI-based health data analysis, and on Nov 5, 2025, it emphasized international expansion. A 1-for-100 reverse stock split, announced Nov 12, 2025, sought Nasdaq bid-price compliance. Today’s large North American order builds directly on these product and market-expansion efforts.

Regulatory & Risk Context

Active S-3 Shelf Registration 2025-07-03

The company has an active Form F-3 shelf filed on 2025-07-03, expiring on 2028-07-03, with at least one usage via a 424B5 on 2025-10-17. Specific shelf size is not provided here, but the structure allows registered securities offerings during the effective period.

Market Pulse Summary

The stock surged +61.1% in the session following this news. A strong positive reaction aligns with UTime securing a nearly $10 million smart health device order totaling 50,000 units, building on prior wearable launches and AI initiatives. Historically, product and expansion news saw mixed short-term impact, while some R&D updates drew stronger interest. Investors would need to weigh this commercial validation against prior reverse-split and financing activity and the stock’s position far below its 200-day MA.

Key Terms

ECG medical

"25,000 units of the UR08 ECG Smart Ring."

An ECG (electrocardiogram) records the heart’s electrical activity through small sensors on the skin and produces a waveform that shows heart rate, rhythm and signs of stress or damage—think of it as a seismograph for the heart’s electrical signals. Investors care because ECGs are central to diagnosing and monitoring cardiac safety in clinical trials, required for regulatory approval of many drugs and devices, and drive demand for related medical equipment and services.

FDA-certified regulatory

"combines FDA-certified medical-grade monitoring technology with everyday wearable"

A term often used to signal that a product, facility or process has met some requirement of the U.S. Food and Drug Administration (FDA), but it is not a single, formal FDA designation. Think of it like a product label that suggests official approval or acceptance—like a “quality badge” on a package—yet the exact meaning can range from full FDA approval to simple registration or listing; investors should verify the specific type and scope of FDA action because that affects regulatory risk and commercial prospects.

medical-grade medical

"FDA-certified medical-grade monitoring technology with everyday wearable scenarios"

Medical-grade describes products, materials or devices manufactured and tested to meet standards required for clinical or hospital use, including higher purity, sterilization and quality controls than consumer versions. Think of it as 'built to hospital standards' the way safety-certified equipment differs from home gadgets. For investors, medical-grade status matters because it influences regulatory approval, pricing, market access, liability and the likelihood of stable contracts and higher profit margins.

FOB technical

"follows internationally recognized trade frameworks, covering FOB Hong Kong delivery"

FOB (Free On Board) is a shipping contract term that specifies the exact point when ownership, shipping costs, and liability for goods shift from the seller to the buyer. Think of it like handing over the keys when a car crosses a line: once the goods pass that point (often the seller’s dock or the ship’s rail), the buyer is responsible for transport, insurance, and any loss. For investors, FOB affects cash flow, inventory timing, and which party bears shipping risk and expense, all of which influence profit margins and balance-sheet reporting.

AI-generated analysis. Not financial advice.

SHENZHEN, China, Dec. 31, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices today announced a major commercial breakthrough. UTime’s Hong Kong subsidiary, UTime Technology (HK) Company Limited, has officially signed a smart health device procurement agreement worth nearly $10 million USD with Tumu Vertex LLC, a Denver-based entity, marking a crucial step in UTime's strategic deployment in the North American medical-grade smart wearable market.

Under the signed Sales Agreement, Tumu Vertex LLC has placed an initial purchase order for 50,000 premium smart health devices from UTime, comprising:

• 25,000 units of the UT-168 BT Blood Pressure Watch and 25,000 units of the UR08 ECG Smart Ring.
  
  
• 25,000 units of the UT-368 4G Blood Pressure Watch and 25,000 units of the UR01 Smart Ring
  
  

We believe this collaboration represents not only a breakthrough in volume but also brings us to a new level in technological integration. UTime's solution perfectly combines FDA-certified medical-grade monitoring technology with everyday wearable scenarios, representing the latest development trend in the smart health industry. The agreement follows internationally recognized trade frameworks, covering FOB Hong Kong delivery, phased payments, and standardized quality assurance systems.

"This cooperation represents a significant strategic breakthrough for us in the North American market," stated UTime's CEO during the signing ceremony. "As our important partner in Colorado, Tumu Vertex's order for 50,000 units demonstrates not only market recognition of our technological capabilities but also opens the door to the North American medical-grade wearable market. We aim to use this opportunity to accelerate the development and implementation of next-generation health monitoring technologies as part of our product portfolio."

The founder and Chief Executive Officer of Tumu Vertex LLC, Monil Hossain, commented: "UTime's technological innovation and product quality have deeply impressed us. These devices will be used for our smart health service platform in the United States, providing users with 24/7 health monitoring solutions. We look forward to establishing long-term strategic cooperation with UTime."

According to the agreement, the first batch of products will begin delivery in the first quarter of 2026, with all products undergoing joint quality control procedures established by both parties.

As populations worldwide are living longer and obtaining greater health awareness, UTime believes the smart health device market is primed for explosive growth. We believe this major purchase order will help consolidate UTime’s position in the consumer electronics field while laying a solid foundation for the company's strategic growth in the medical technology sector.

About UTime Limited

Trading under the NASDAQ ticker WTO, UTime Limited is engaged in the design, development, production, sales and brand operation of mobile devices and smart wearable devices and other technology in China and globally. The company aims to provide cost-effective products while serving a broad customer base.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. For additional risk factors, please review UTime Limited’s Annual Report on Form 20-F and other SEC filings. Forward-looking statements are made only as of the date of this release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable law.

Contact:
qhengcong@utimemobile.com

UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 865122

FAQ

What did UTime (WTO) announce on December 31, 2025?

UTime announced a nearly $10 million sales agreement with Tumu Vertex for 50,000 smart health devices.

How are the 50,000 devices for WTO ordered by Tumu Vertex allocated?

The order is described as 25,000 UT-168 BT Blood Pressure Watches and 25,000 UR08 ECG Smart Rings.

When will UTime begin shipping the WTO devices to Tumu Vertex?

The first batch is scheduled for delivery beginning in Q1 2026.

What delivery and payment terms did WTO report for the Tumu Vertex order?

The agreement covers FOB Hong Kong delivery and phased payments with joint quality control procedures.

Does UTime say the devices are medical-grade for WTO investors?

UTime states the devices combine FDA-certified medical-grade monitoring with everyday wearable designs.

What does the Tumu Vertex order mean for UTime's (WTO) North American strategy?

UTime describes the order as a strategic breakthrough to accelerate its entry into the North American medical-grade wearable market.